Ryan E. Temel
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Surgery top 1%
- Cholesterol and Lipid Metabolism
- Lipoproteins and Cardiovascular Health
Papers in
- Surgery 41
- Cholesterol and Lipid Metabolism 35
- Lipoproteins and Cardiovascular Health 8
-
- Peroxisome Proliferator-Activated Receptors 11
- Co-authors
- David L. Williams (9 shared papers)Lawrence L. Rudel (13 shared papers)Kathryn J. Moore (3 shared papers)Katey J. Rayner (3 shared papers)Farah Hussain (2 shared papers)Edward A. Fisher (2 shared papers)Frederick J. Sheedy (2 shared papers)Janine M. van Gils (2 shared papers)
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (8 papers)Journal of Biological Chemistry (6 papers)Journal of Lipid Research (5 papers)PLoS ONE (4 papers)Cell Metabolism (2 papers)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Ryan E. Temel
58 papers receiving 4.2k citations
Ryan E. Temel's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 1.3k
- Surgery 2.0k
- Endocrinology, Diabetes and Metabolism 708
- Biochemistry 238
- Molecular Biology 2.0k
Countries citing papers authored by Ryan E. Temel
This map shows the geographic impact of Ryan E. Temel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan E. Temel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan E. Temel more than expected).
Fields of papers citing papers by Ryan E. Temel
This network shows the impact of papers produced by Ryan E. Temel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan E. Temel. The network helps show where Ryan E. Temel may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan E. Temel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis Hit paper breakdown → | 2011 | 566 |
| 2 | Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides Hit paper breakdown → | 2011 | 556 |
| 3 | 2007 | 298 | |
| 4 | 1996 | 215 | |
| 5 | XX sex chromosome complement promotes atherosclerosis in mice Hit paper breakdown → | 2019 | 212 |
| 6 | 1997 | 207 | |
| 7 | 1999 | 169 | |
| 8 | 1999 | 156 | |
| 9 | 1999 | 105 | |
| 10 | 2005 | 95 | |
| 11 | 2010 | 94 | |
| 12 | 2003 | 93 | |
| 13 | 1998 | 80 | |
| 14 | 2018 | 79 | |
| 15 | 2012 | 73 | |
| 16 | 2014 | 70 | |
| 17 | 2020 | 65 | |
| 18 | 2012 | 64 | |
| 19 | 2016 | 61 | |
| 20 | 2019 | 57 |
About Ryan E. Temel
Ryan E. Temel is a scholar working on Surgery, Molecular Biology, Cancer Research, Oncology and Endocrinology, Diabetes and Metabolism, having authored 58 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (35 papers), Drug Transport and Resistance Mechanisms (14 papers), Cancer, Lipids, and Metabolism (11 papers), Peroxisome Proliferator-Activated Receptors (11 papers), Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), MicroRNA in disease regulation (5 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Cancer Research (1.3k citations), Surgery (2.0k citations), Endocrinology, Diabetes and Metabolism (708 citations), Biochemistry (238 citations) and Molecular Biology (2.0k citations). Ryan E. Temel has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include David L. Williams, Lawrence L. Rudel, Kathryn J. Moore, Katey J. Rayner, Farah Hussain, Edward A. Fisher, Frederick J. Sheedy, Janine M. van Gils, Carlos Fernández‐Hernando and Christine Esau. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Biological Chemistry, Journal of Lipid Research, PLoS ONE and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.